Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study

por Deodhar, Atul A., Shiff, Natalie J., Gong, Cinty, Hsia, Elizabeth C., Lo, Kim Hung, Kim, Lilliane, Xu, Stephen, Reveille, John D.
Publicado 2022

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

por Deodhar, Atul A, Combe, Bernard, Accioly, Ana P, Bolce, Rebecca, Zhu, Danting, Gellett, Amanda M, Sprabery, Aubrey Trevelin, Burmester, Gerd-Rüdiger R
Publicado 2022

Effect of Secukinumab on Patient‐Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)

por Deodhar, Atul A., Dougados, Maxime, Baeten, Dominique L., Cheng‐Chung Wei, James, Geusens, Piet, Readie, Aimee, Richards, Hanno B., Martin, Ruvie, Porter, Brian
Publicado 2016

Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results

por Deodhar, Atul A., Mease, Philip J., Rahman, Proton, Navarro-Compán, Victoria, Strand, Vibeke, Hunter, Theresa, Bolce, Rebecca, Leon, Luis, Lauzon, Steve, Marzo-Ortega, Helena
Publicado 2021

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis

por Mease, Philip J, Deodhar, Atul A, van der Heijde, Désirée, Behrens, Frank, Kivitz, Alan J, Neal, Jeffrey, Kim, Jonghyeon, Singhal, Shalabh, Nowak, Miroslawa, Banerjee, Subhashis
Publicado 2022

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

por Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert A, van der Heijde, Désirée, Inman, Robert D, Deodhar, Atul A, Baratelle, Anna, Xu, Stephen, Xu, Weichun, Hsu, Benjamin
Publicado 2011

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of poole...

por Schreiber, Stefan, Colombel, Jean-Frederic, Feagan, Brian G, Reich, Kristian, Deodhar, Atul A, McInnes, Iain B, Porter, Brian, Das Gupta, Ayan, Pricop, Luminita, Fox, Todd
Publicado 2019

Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications

por Merola, Joseph F., McInnes, Iain B., Deodhar, Atul A., Dey, Amit K., Adamstein, Nicholas H., Quebe-Fehling, Erhard, Aassi, Maher, Peine, Michael, Mehta, Nehal N.
Publicado 2022

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

por Deodhar, Atul A., Miceli‐Richard, Corine, Baraliakos, Xenofon, Marzo‐Ortega, Helena, Gladman, Dafna D., Blanco, Ricardo, Das Gupta, Ayan, Martin, Ruvie, Safi, Jorge, Porter, Brian, Shete, Abhijit, Rosenbaum, James T.
Publicado 2020

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

por Elewski, Boni E., Baddley, John W., Deodhar, Atul A., Magrey, Marina, Rich, Phoebe A., Soriano, Enrique R., Soung, Jennifer, Bao, Weibin, Keininger, Dorothy, Marfo, Kwaku, Patekar, Manmath, Sharma, Abhishek, Shete, Abhijit, Lebwohl, Mark Gabriel
Publicado 2021